Wie Svenka schrieb ging es da meine ich um den Boostereinsatz.
Corbevax and Covovax - are unlikely to be used for booster shots, Dr Arora told NDTV.
India has, so far, administered nearly 147 crore doses, of which around 61.8 crore are second doses.
The government's decision to not mix-and-match vaccines follows the World Health Organization saying it is advisable to ensure people get the same drug they were initially given.
In July last year the WHO's Chief Scientist, Dr Soumya Swaminathan, said mixing and matching vaccines was "a bit of a data-free, evidence-free zone."
Mixing and matching of vaccines should only be done if there is a supply constraint, the WHO said.
Vaccine combinations, already used by some governments, could help low- and middle-income countries manage stockpiles and deal with vaccine shortages as the Omicron variant spreads.
The European Union has endorsed the mixing of two different shots for both initial vaccine schedules and boosters, and the United States, in October, said it would allow 'mix-and-match' boosters.
Weiterhin versucht Indien Corbevax zu pushen und auch gerne als eigenes Produkt zu vermarkten.
„Last week two more were added to the 'on paper' list - Corbevax, described as ****India's first homegrown**** "RBD protein sub-unit vaccine", and Covovax - as well as the anti-viral drug Molnupiravir.“
|
Thread abonnieren
